The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy
Open accessAbstract
We investigated the mRNA expression levels of all six antiapoptotic Bcl-2 subfamily members in 68 human cancer cell lines using qPCR techniques and measured the ability of known Bcl-2 inhibitors to induce cell death in 36 of the studied tumor cell lines. Our study reveals that Mcl-1 represents the anti-apoptotic Bcl-2 subfamily member with the highest mRNA levels in the lung, prostate, breast, ovarian, renal, and glioma cancer cell lines. In leukemia/lymphoma and melanoma cancer cell lines, Bcl-2 and Bfl-1 had the highest levels of mRNA, respectively. The observed correlation between the cell killing properties of known Bcl-2 inhibitors and the relative mRNA expression levels of anti-apoptotic Bcl-2 proteins provide critical insights into apoptosis-based anticancer strategies that target Bcl-2 proteins. Our data may explain current challenges of selective Bcl-2 inhibitors in the clinic, given that severe expression of Bcl-2 seems to be limited to leukemia cell lines. Furthermore, our data suggest that in most cancer types a strategy targeted to Mcl-1 inhibition, or combination of Bfl-1 and Mcl-1 inhibition for melanoma, may prove to be more successful than therapies targeting only Bcl-2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Bcl-2 Protein Family: Arbiters of Cell Survival
Adams, J. M., & Cory, S. (1998) · Science · doi:10.1126/science.281.5381.1322 · Cited by 5,332
The Pathophysiology of Mitochondrial Cell Death
Green, D. R., & Kroemer, G. (2004) · Science · doi:10.1126/science.1099320 · Cited by 3,418
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Self-citationQuantification of mRNA using real-time RT-PCR
Nolan, T., Hands, R. E., & Bustin, S. A. (2006) · Nature Protocols · doi:10.1038/nprot.2006.236 · Cited by 2,247
ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
Tse, C., Shoemaker, A. R., Adickes, J., Anderson, M. G., Chen, J., Jin, S., Johnson, E. F., Marsh, K. C., Mitten, M. J., Nimmer, P., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5836 · Cited by 1,992
Promoting apoptosis as a strategy for cancer drug discovery
Fesik, S. W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1736 · Cited by 1,098
McDonnell, T. J., Troncoso, P., Brisbay, S. M., Logothetis, C. J., Chung, L. W. K., Hsieh, J., Tu, S., & Campbell, M. L. (1992) · PubMed · Cited by 1,049
Konopleva, M., Contractor, R., Tsao, T., Samudio, I., Ruvolo, P. P., Kitada, S., Deng, X., Zhai, D., Shi, Y.-X., Sneed, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.006 · Cited by 1,023
Self-citationDysregulation of Apoptosis in Cancer
Reed, J. C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2941 · Cited by 987
Self-citationImmunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers.
Krajewska, M., Krajewski, S., Epstein, J. I., Shabaik, A. S., Sauvageot, J., Song, K. B., Kitada, S., & Reed, J. C. (1996) · Europe PMC (PubMed Central) · Cited by 593
Self-citationWang, C.-Y., Guttridge, D. C., Mayo, M. W., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.5923 · Cited by 590
Raisova, M., Hossini, A. M., Eberle, J., Riebeling, C., Orfanos, C. E., Geilen, C. C., Wieder, T., Sturm, I., & Daniel, P. T. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01409.x · Cited by 575
Phosphorylation of Bcl2 and regulation of apoptosis
Ruvolo, P., Deng, X., & May, W. (2001) · Leukemia · doi:10.1038/sj.leu.2402090 · Cited by 504
Solution structure of the antiapoptotic protein bcl-2
Petros, A. M., Medek, A., Nettesheim, D. G., Kim, D. H., Yoon, H. S., Swift, K., Matayoshi, E. D., Oltersdorf, T., & Fesik, S. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041619798 · Cited by 458
Structural insights into the degradation of Mcl-1 induced by BH3 domains
Czabotar, P. E., Lee, E. F., van Delft, M. F., Day, C. L., Smith, B. J., Huang, D. C. S., Fairlie, W. D., Hinds, M. G., & Colman, P. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701297104 · Cited by 446
An informatics approach identifying markers of chemosensitivity in human cancer cell lines.
Amundson, S. A., Myers, T. G., Scudiero, D. A., Kitada, S., Reed, J. C., & Fornace, A. J. (2000) · PubMed · Cited by 408
Self-citationChen, S., Dai, Y., Harada, H., Dent, P., & Grant, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3964 · Cited by 385
Mcl-1 is a potential therapeutic target in multiple types of cancer
Akgul, C. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8637-6 · Cited by 329
Vogler, M., Butterworth, M., Majid, A., Walewska, R. J., Sun, X.-M., Dyer, M. J. S., & Cohen, G. M. (2009) · Blood · doi:10.1182/blood-2008-08-173310 · Cited by 323
O'Brien, S., Moore, J. O., Boyd, T. E., Larratt, L. M., Skotnicki, A., Koziner, B., Chanan-Khan, A. A., Seymour, J. F., Bociek, R. G., Pavletic, S., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.1191 · Cited by 303
Comparison of chemical inhibitors of antiapoptotic Bcl-2-family proteins
Zhai, D., Jin, C., Satterthwait, A. C., & Reed, J. C. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401937 · Cited by 234
Self-citationDifferent forms of cell death induced by putative BCL2 inhibitors
Vogler, M., Weber, K., Dinsdale, D., Schmitz, I., Schulze-Osthoff, K., Dyer, M. J. S., & Cohen, G. M. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.48 · Cited by 203
Ding, Q., He, X., Xia, W., Hsu, J.-M., Chen, C.-T., Li, L.-Y., Lee, D.-F., Yang, J.-Y., Xie, X., Liu, J.-C., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1788 · Cited by 194
Martin, B., Paesmans, M., Berghmans, T., Branle, F., Ghisdal, L., Mascaux, C., Meert, A.-P., Steels, E., Vallot, F., Verdebout, J.-M., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601095 · Cited by 163
Androgens induce resistance to bcl-2-mediated apoptosis in LNCaP prostate cancer cells.
Berchem, G., Bosseler, M., Sugars, L. V. Y., Voeller, H. J., Zeitlin, S., & Gelmann, E. P. (1995) · PubMed · Cited by 150
Mcl-1 Is Required for Melanoma Cell Resistance to Anoikis
Boisvert-Adamo, K., Longmate, W. M., Abel, E. V., & Aplin, A. E. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0358 · Cited by 137
Selzer, E., Schlagbauer‐Wadl, H., Okamoto, I., Pehamberger, H., P�tter, R., & Jansen, B. (1998) · Melanoma Research · doi:10.1097/00008390-199806000-00001 · Cited by 134
Strik, H. M., Deininger, M., Streffer, J. R., Grote, E. H., Wickboldt, J., DICHGANS, J., Weller, M., & Meyermann, R. (1999) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.6.763 · Cited by 133
Zapata, J. M., Krajewska, M., Krajewski, S., Huang, R., Takayama, S.-I. J., Wang, H., Adamson, E. D., & Reed, J. C. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1005940832123 · Cited by 108
Self-citationIncreased MCL–1 Expression Is Associated with Poor Prognosis in Ovarian Carcinomas
Shigemasa, K., Katoh, O., Shiroyama, Y., Mihara, S., Mukai, K., Nagai, N., & Ohama, K. (2002) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2002.tb01289.x · Cited by 99
Downregulation of Bfl-1 protein expression sensitizes malignant B cells to apoptosis
Brien, G., Trescol-Biemont, M.-C., & Bonnefoy, N. (2007) · Oncogene · doi:10.1038/sj.onc.1210363 · Cited by 84
Wolter, K. G., Verhaegen, M. E., Fernández, Y., Nikolovska‐Coleska, Z., Riblett, M., de la Vega, C. M., Wang, S., & Soengas, M. S. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402163 · Cited by 75
Three-dimensional structures of proteins involved in programmed cell death
Liang, H., & Fesik, S. W. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1415 · Cited by 74
Apogossypol derivatives as antagonists of antiapoptotic Bcl-2 family proteins
Wei, J., Kitada, S., Rega, M. F., Emdadi, A., Yuan, H., Cellitti, J. F., Stebbins, J. L., Zhai, D., Sun, J., Yang, L., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1050 · Cited by 67
Self-citationWei, J., Kitada, S., Rega, M. F., Stebbins, J. L., Zhai, D., Cellitti, J. F., Yuan, H., Emdadi, A., Dahl, R. S., Zhang, Z., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900472s · Cited by 60
Self-citationBackus, H. H. J., van Riel, J., van Groeningen, C. J., Vos, W., Dukers, D. F., Bloemena, E., Wouters, D., Pinedo, H. M., & Peters, G. J. (2001) · Annals of Oncology · doi:10.1023/a:1011112227044 · Cited by 58
MCL-1 Promoter Insertions Dial-Up Aggressiveness of Chronic Leukemia
Kitada, S., & Reed, J. C. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh153 · Cited by 28
Self-citation
Cited by
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
Czabotar, P. E., Lessene, G., Strasser, A., & Adams, J. M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3722 · Cited by 3,219
The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics
Hata, A. N., Engelman, J. A., & Faber, A. C. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0011 · Cited by 619
Favaloro, B., Allocati, N., Graziano, V., Di Ilio, C., & De Laurenzi, V. (2012) · Aging · doi:10.18632/aging.100459 · Cited by 585
Han, K., Jeng, E. E., Hess, G. T., Morgens, D. W., Li, A., & Bassik, M. C. (2017) · Nature Biotechnology · doi:10.1038/nbt.3834 · Cited by 498
Calcium, mitochondria and cell metabolism: A functional triangle in bioenergetics
Rossi, A., Pizzo, P., & Filadi, R. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.10.016 · Cited by 489
Metadata
- Authors
- Placzek, W. J., Wei, J., Kitada, S., Zhai, D., Reed, J. C., & Pellecchia, M.
- Venue
- Cell Death & Disease
- Published
- 2010-05-06
- Volume
- 1
- Issue
- 5
- Pages
- e40-e40
- ISSN
- 2041-4889 (ISSN-L)
- OpenAlex
- W2024613683
- Cited by
- 294
- References
- 37
- FWCI
- 6.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.